Physician profile
Aileen E Rosenberg
NPI 1578705984
$986.02
in general payments reported to CMS, 2019-2025
12 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $275 · 2022: $590 · 2023: $20.81 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $121.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $454.70 | 2022 | |
| Boston Scientific Corporation | $116.44 | 2021-2025 | Intracept |
| Nevro Corp. | $110.15 | 2021 | |
| Biodelivery Sciences International, INC. | $76.42 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.29 | 2021 | |
| Collegium Pharmaceutical, INC. | $45.77 | 2022-2023 | Xtampza |
| Tersera Therapeutics LLC | $45.07 | 2022 | |
| Scilex Pharmaceuticals INC. | $21.38 | 2022 | |
| Lilly USA, LLC | $16.75 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $14.10 | 2022 | |
| Almatica Pharma LLC | $13.25 | 2021 | |
| Fidia Pharma USA INC. | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aileen Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.